Essential oil nebulization in mild COVID-19(EONCO): Early phase exploratory clinical trial
Research article
[키워드] Anosmia
antiviral action
appear
approach
Asymptomatic
benefit
carried
clearance
clinical trial
Combination
Concentration
coronavirus disease
COVID-19
doses
Efficacy
essential oil
Eucalyptus oil
evaluated
Evolution
exploratory
frequencies
Inconclusive
Mild
multiple ascending dose
objective
Open-label
participant
Peppermint oil
phase
Placebo
polymerase chain
produced
Randomized
reached
reduced
respiratory symptom
Result
reverse transcription
Safety
significantly
Steroids
study participant
Symptom
symptomatic
Symptomatic relief
Tea tree oil
Therapeutic benefit
therapeutic efficacy
Toxicity
Treatment
Viremia
with mild disease
[DOI] 10.1016/j.jaim.2022.100626 [Article Type] Research article
[DOI] 10.1016/j.jaim.2022.100626 [Article Type] Research article